SIML Simlatus Corp

Simlatus No Longer Shell-Risk & Retires $1.7M in Convertible Debt

Simlatus No Longer Shell-Risk & Retires $1.7M in Convertible Debt

SAN FRANCISCO, CA, June 20, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a company that operates multiple revenue streams in the CBD Industry, Major Broadcast Industry and Internet Provider Industry, announces today that Chairman and CEO, Richard Hylen, has provided the following statements.

Richard Hylen, Chairman and CEO, stated, “Simlatus Corporation is no longer considered a Shell-Risk by OTC Markets.  The Company’s most recent disclosure statements and Balance Sheet indicate satisfactory revenue and assets.  We need to prove to our shareholders and investors a vote of confidence by the Markets and that our Company is on a sound path for the future.

On June 3, 2019 the Company repurchased 18,159 shares of Series A at $1.79 per share from Optempus Investments.  This transaction prohibited the conversion of 3,250,000 common shares of stock.

Additionally, on June 13, 2019 the Company cancelled $2,200,000 in convertible Warrants in exchange of Preferred Series C stock having a value of $457,500 and a 6 month holding period with volume restrictions. This exchange and repurchase continues to support our corporate directive to reduce dilution and provide greater returns for the shareholders and investors of Simlatus Corporation.”

Safe Harbor for Forward-Looking Statements: This news release contains forward-looking statements which are not statements of historical fact. Forward-looking statements include estimates and statements that describe the Company’s future plans, objectives or goals, including words to the effect that the Company or management expects a stated condition or result to occur. Forward-looking statements may be identified by such terms as “believes”, “anticipates”, “expects”, “estimates”, “may”, “could”, “would”, “will”, or “plan”. Since forward-looking statements are based on assumptions and address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although these statements are based on information currently available to the Company, the Company provides no assurance that actual results will meet management’s expectations. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to changes in general economic and financial market conditions. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or  obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.

Contact:

Richard Hylen, CEO Tel: (530) 205-3437
EN
20/06/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Simlatus Corp

 PRESS RELEASE

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System

SIML Proscere Bioscience Receives $16M CBD Order on New Hybrid System SAN FRANCISCO, CA, Aug. 01, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”), a holding company currently focused on opportunities in the cannabis space that owns and operates a number of subsidiaries, all with multiple revenue streams, diversified in cannabis processing products, commercial broadcasting and support services to AT&T’s DirecTV products. Today the company announces that it has received another purchase order from United Opportunities LLC on ...

 PRESS RELEASE

SIML Proscere Bioscience Positions Long Term Strategy

SIML Proscere Bioscience Positions Long Term Strategy San Francisco, California, July 24, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the company’s diver...

 PRESS RELEASE

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor

SIML Proscere Bioscience Waltzing With Largest Cannabis Processor San Francisco, California, July 16, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on the CBD industry. In addition, the com...

 PRESS RELEASE

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD...

SIML Proscere Bioscience Receives a $4.3M Order for Its Cold-Water CBD/Hemp Extraction Systems from Brand House Ventures Inc. San Francisco, California, July 15, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’...

 PRESS RELEASE

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Ind...

SIML Drives-Down Debt and Increases Profits From the $50B Cannabis Industry With NASDAQ on the Horizon San Francisco, California, July 09, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Simlatus Corporation (OTC PINK: SIML) (“Simlatus” or the “Company”) is a holding company focused on opportunities in the cannabis space. The Company owns and operates a number of subsidiaries with multiple revenue streams. While acquisitions of companies in the hemp sector accelerate worldwide as industrial and consumer hemp/CBD markets develop, our Proscere Bioscience is the company’s division focused on t...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch